Candel Therapeutics to Present at TD Cowen’s 46th Annual Health Care Conference in Boston

Candel is a clinical-stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to ...
IEEE

Quality Assessment for Talking Head Videos via Multi-Modal Feature Representation

Abstract: The extensive application prospects of digital humans have brought about unprecedented attention to the quality evaluation of talking head (TH) videos. Most existing TH video quality ...

Candel Therapeutics Announces Pricing of Public Offering

Citigroup, Cantor, and Stifel are acting as joint bookrunning managers for the offering. LifeSci Capital is acting as lead manager for the offering. H.C. Wainwright & Co. and Brookline Capital Markets ...
TMCnet

Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localize…

RTW committed $100M in U.S. launch funding, subject to U.S. Food and Drug Administration (FDA) approval of aglatimagene ...
IEEE

Multi-Modal Timely Pancreatitis Severity Assessment via Hierarchical Evidential Conflictive Learning

Abstract: Acute pancreatitis (AP) can rapidly progress to severe acute pancreatitis (SAP), which carries a high risk of mortality. Early screening of high-risk patients using computed tomography (CT) ...
TMCnet

PSI and Association of Accounting Technicians Renew Long-Term Partnership to Support the Future of Accounting Assessments

PSI, a global leader in assessment solutions, announced today that it has secured a renewal of its partnership agreement with ...